TABLE 2

Patient baseline characteristics measured at screening (ITT population)

These data were obtained by post hoc analyses.

CharacteristicTotal (N = 44)
Predicted normal FEV1, %, mean (range)73.87 (60.3, 96.5)
FEV1/FVC, %, mean (range)67.98 (45.9, 87.2)
FEV1 reversibility, %, mean (range)21.17 (11.9, 50.8)
FeNO, ppb, geo meana28.64
Blood eosinophil count, 109/l, geo mean0.266
  • geo, geometric; ppb, parts per billion.

  • a Measurements taken at pre-dose day 1 of treatment period 1.